Neurotransmitters are small molecules that orchestrate complex patterns of brain activity. Unfortunately, there exist few sensors capable of directly detecting individual neurotransmitters. Those sensors that do exist are either unspecific or fail to capture the temporal or spatial dynamics of neurotransmitter release. DNA-stabilized silver nanoclusters (DNA-AgNCs) are a new class of biocompatible, fluorescent nanostructures that have recently been demonstrated to offer promise as biosensors. In this work, we identify two different DNA sequences which form dopamine-sensitive nanoclusters. We demonstrate that each sequence supports two distinct DNA-AgNCs capable of providing specific, ratiometric fluorescent sensing of dopamine concentration in vitro. DNA-Ag nanoclusters therefore offer a novel, low-cost approach to quantification of dopamine, creating the potential for real-time monitoring in vivo.
INTRODUCTION
Neurotransmitters (NTs) are small molecules used in signaling pathways throughout the nervous system. The dynamic patterns of neurotransmitter signaling are critical to brain function and tightly regulated, both temporally and spatially. Improper release, reuptake, and/or degradation of neurotransmitters has been implicated in a wide range of neurodevelopmental, neurological and neurodegenerative disorders, from epilepsy 1 to depression 2 to Parkinson's disease. 3 Monitoring patterns of neurotransmitter release in the brain would provide fundamental insights into brain function and could serve as a diagnostic tool for maladaptive mental states and diseases. However, the ability to quantify specific endogenous neurotransmitters is limited. Current methods to detect neurotransmitters are predominantly electrochemical. Certain molecules, including the biogenic amines (which include dopamine, epinephrine, serotonin, and ascorbic acid) can be oxidized by an applied potential, allowing nearby microelectrodes to detect the chemical reaction as an electrical signal. 4 The time resolution of these methods is as fast as the electrochemical reaction, but the specificity is low: the applied potential will oxidize any biogenic amine present. Constant-potential amperometry has been adapted to increase performance; the resulting fast-scan cyclic voltammetry is now coupled with microdialysis to detect the biogenic amines [5] [6] [7] (as well as oxygen and pH 8 ) more reliably in vivo.
However, while electrochemical methods provide the millimeter spatial and millisecond temporal resolution adequate for neuro-signal sensing, 9 their lack of specificity severely limits signal interpretation. Furthermore, the family of electrochemical techniques is simply not applicable to other small molecules, including the major neurotransmitters, glutamate and GABA. Further research is needed to enable specific and reliable detection of individual neurotransmitters with appropriate spatiotemporal resolution.
The use of optically active nanomaterials for specific binding and fluorescent detection is an emerging and promising approach to in vivo sensing of biomolecules. [10] [11] [12] However, widespread utility will be limited if complex design or costly synthesis is required for each biological target. DNA-stabilized fluorescent silver nanoclusters (DNA-AgNCs) are a new class of fluorescent nanostructure formed when a particular sequence of single-stranded DNA stabilizes a few-atom cluster of silver. 13, 14 DNA-AgNCs offer certain key advantages as biosensors. DNA-AgNCs are relatively cheap and easy to synthesize, and are biocompatible. 15 The fluorescence of a DNA-AgNC is largely determined by the stabilizing DNA sequence and therefore readily manipulated [16] [17] [18] . Perturbations to the local environment or DNA conformation of DNA-AgNCs can produce measureable changes in their emissive properties. 16, 19 These combined properties have led to the use of DNA-AgNC probes as novel fluorescent sensors for metal ions and DNA sequences in complex biological matrices. [20] [21] [22] We theorized that DNA-stabilized AgNC probes could serve as fluorescent sensors for biologically relevant small molecules, such as neurotransmitters.
Here we demonstrate that DNA-AgNCs can be specifically sensitive for dopamine. We identify two distinct DNA-AgNCs which show preference for dopamine over other neurotransmitters. These two DNA probes enable two classes of dopamine sensing: one provides a "turn-on" fluorescent sensor in the presence of dopamine and the other provides a "turn-off" fluorescent sensor. Importantly, we determined that these two DNA sequences each produced silver nanocluster populations with distinct spectral populations. The nanocluster populations responded differentially to dopamine, providing a ratiometric measure of dopamine concentration in vitro. We validated that these DNA-AgNC probes were responsive to dopamine, but insensitive to other common neurotransmitters, related catecholamines, and known competitors. We therefore present DNA-AgNCs as novel, biocompatible sensors of dopamine with potential for quantitative, ratiometric, optical in vivo sensing of neurotransmitters.
RESULTS & DISCUSSION
We hypothesized that DNA-stabilized silver nanoclusters could be used as sensors of small molecule neurotransmitters. We selected six DNA 'template' sequences (sequences S1-S6, Table 1 ) known to stabilize silver atoms into fluorescent nanoclusters, 16, 17, 23, 24 and synthesized AgNCs on each using a standard approach: addition of AgNO 3 followed by reduction using NaBH 4 . We first determined the basal fluorescence of the DNA-AgNC created by each probe (Figure 1a ). In these initial screens, we used UV excitation (260 nm) because it universally excites fluorescent DNA-AgNCs regardless of their specific visible excitation spectra. 25 In the absence of neurotransmitter, all six template sequences produced bright, stable DNA-AgNCs with emission peaks between 500-800 nm (Figure 1a ) consistent with previous reports (see Figure S1 and Supporting Information for spectral details).
To identify potential DNA-AgNC sensors for neurotransmitter (NT) detection, we screened a library of eight well-studied NTs (acetylcholine, L-aspartic acid, dopamine, epinephrine, GABA, L-glutamic acid, glycine, and histamine, see Supplementary Figure S5 for chemical structures) against the six DNA-AgNCs (Figure 1b-c) . We used the peak emission of each probe (represented as white) to gauge the change in intensity elicited by the presence of NT either during or after nanocluster synthesis. We first tested whether emission intensity was altered by the presence of NT during synthesis (Figure 1b) . Of all the NTs tested, dopamine produced the greatest changes in DNA-AgNC fluorescence. When nanoclusters were assembled in the presence of dopamine, samples containing templates S1-3 fluoresced less, while templates S4-6 fluoresced more than DNA-AgNCs assembled in the absence of neurotransmitter. We then determined whether the fluorescence of assembled DNA-AgNC nanoclusters was altered by the addition of NTs after synthesis (Figure 1c) . Most DNA-AgNCs showed mild reductions in fluorescence when NT was added. However, when dopamine was added, the fluorescence of assembled DNA-AgNCs formed using sequences S1, S2, S3 and S5 decreased profoundly.
Of the six DNA-AgNCs tested, two showed promise for sensor development. The fluorescence of nanoclusters assembled using DNA sequence S4 increased dramatically in the presence of dopamine during synthesis, though it was largely unaffected by other NTs (Figure 1b , boxed column S4). Conversely, the fluorescence of assembled DNA S5 nanoclusters declined dramatically upon addition of dopamine, but was unchanged by other NTs (Figure 1c , boxed column S5). The fluorescence emission of DNA S2-AgNCs and DNA S3-AgNCs were similar to DNA S5-AgNCs, but DNA S5-AgNCs exhibited a stronger quenching response and was more selective to dopamine. We therefore focused our efforts on the two strongly dopamineresponsive DNA sequences, S4 and S5.
DNA S4 silver nanoclusters as ratiometric, "turn-on" dopamine sensors
Our initial screens identified neurotransmitter-responsive DNA-AgNCs using universal UV excitation at 260 nm and monitoring emission at the specific wavelength in the visible spectrum where intensity was greatest in the absence of NT. For our focused studies, we tailored the excitation wavelength to the individual construct and collected emission spectra. We first turned our attention to the silver nanoclusters assembled by DNA sequence S4. Collecting a full emission spectrum from the DNA S4-AgNCs using 525 nm excitation revealed an emission peak at 625 nm that more than doubled in intensity when dopamine was present (Figure 2c ) but was barely changed by the other compounds tested (Figure 2b) .
The S4 template was also exceptional in that its excitation with UV (260 nm) illumination clearly revealed two spectrally distinct clusters (Figure 2d ). When illuminated with visible light at their respective peak excitation wavelengths, one cluster has a peak emission wavelength of 625 nm (as reported previously 23 ) and the other has peak emission at 730 nm (not previously reported) (Figure 1a, Figure 2d ). The presence of dopamine during nanocluster formation dramatically increases the 625 nm peak, while decreasing the 730 nm peak (Figure 2d) .
We systematically tested the effect of dopamine concentration on the formation of these two spectrally distinct populations. When DNA-AgNC were templated with sequence S4 in the absence of dopamine, the formation of the near infrared-emitting (730 nm) population was favored (Figure 2d-e ). However, as dopamine concentration increased from 1 µM to 100 µM, nIR fluorescence (730 nm emission) decreased approximately 66% and was effectively quenched at 1 mM dopamine (Figure 2e) . In contrast, red fluorescence (collected at 615 nm) doubled in intensity as dopamine concentration increased from 1 µM to 100 µM (Figure 2e) and was not quenched until 10 mM dopamine. It should be noted that the fluorescence of both constructs decreased above 100 µM dopamine and, at these high concentrations, we observed silver nanoparticle formation and aggregation, which may have been induced directly by dopamine, 12 or by competition for silver between the bases and the excess chloride present from using dopamine-HCl salt in our preparation.
Although nanoparticle formation and aggregation prevent quantitative interpretation at dopamine concentrations over 100 µM (Figure 2e, Figure S3 ), at concentrations below 100 µM, the two emission peaks together provide a reliable, ratiometric signal (F red /F nIR ) that changes by nearly two orders of magnitude (Figure S3 ), a greater dynamic range than either signal alone and comparable to the range of dopamine concentrations it reflects. We therefore propose that the relative fluorescence of the two spectrally distinct and differentially dopaminesensitive DNA S4-AgNC populations (Figure 2a) can provide a robust, quantitative and sensitive measure of dopamine concentration in vitro.
DNA S5 silver nanoclusters as ratiometric, "turn-off" dopamine sensors
We next turned our attention to nanoclusters stabilized by DNA sequence S5. In our initial screens, we observed that, when excited with UV light (260 nm), S5-AgNCs had a peak emission wavelength of 600 nm (Figure 1a ) and a fluorescence intensity that was largely unaffected by the addition of most neurotransmitters (Figure 1c , S5 column). However, when dopamine was added, DNA S5-AgNCs exhibited a ~80% decrease in fluorescence intensity (Figure 1c) . Based on these observations, we scanned excitation wavelengths while holding emission fixed at 600 nm and identified 535 nm as the peak visible excitation wavelength. We then re-assessed the DNA S5-AgNC response to neurotransmitters. Encouragingly, addition of dopamine reduced fluorescence at the 600 nm emission peak even more under 535 nm excitation than under 260 nm excitation, diminishing by nearly two orders of magnitude (96% decrease, Figure 3b-c) . Meanwhile, changes in fluorescence in response to the other NTs were less than 11% (Figure  3b) .
Upon closer inspection, we noticed this response to dopamine was actually a compound effect: under 260 nm excitation adding dopamine to S5-AgNCs both decreased emission at 600 nm and shifted the peak emission from 600 nm to 560 nm (Figure 3d) . Full excitation and emission spectra of the DNA S5-AgNCs revealed two cluster populations with distinct spectral properties: one with a peak emission at 650 nm (580 nm excitation) and another with a peak emission at 575 nm (495 nm excitation) ( Figure S4) . These populations were not resolved using 260 nm excitation (Figure 1a, Figure 3d ) and their sum produced an apparent emission peak at 600 nm.
We examined the dopamine sensitivity of these two spectrally distinct nanocluster populations generated by DNA sequence S5 individually. The shorter wavelength population (495 nm excitation, 575 nm emission) remained stable up to 100 µM dopamine and was only quenched at higher concentrations when aggregation was observed (Figure 3e , green circles). By contrast, dopamine effectively quenched the fluorescence of the longer wavelength population (580 nm excitation, 650 nm emission) in the range of 5-50 µM dopamine (Figure 3e , red triangles). We conclude that the quench+shift phenomenon observed with UV excitation (Figure 3d ) was due to the selective quenching of the longer wavelength population by the moderate amounts of dopamine used in our initial screen (50 µM, schematic in Figure 3a ). We therefore propose that the relative fluorescence of these two spectrally distinct S5-AgNC populations, under visible excitation, can be used as a fluorescent, ratiometric (F 575 /F 650 ) and quantitative "turn-off" sensor (F 575 : invariant calibration, F 650 : indicator) of dopamine concentration in vitro.
Specificity of silver nanoclusters for dopamine over known homologues and competitors
Encouragingly, both S4-and S5-templated silver nanoclusters were highly responsive to dopamine and relatively insensitive to the other neurotransmitters tested. However, we wondered if the sensors would be specific to dopamine over more closely related small molecules. We therefore interrogated both S4-and S5-stabilized AgNCs with catecholamine precursors and metabolites of dopamine (L-tyrosine, phenylalanine, L-DOPA, and DOPAC), as well as with small molecules known to interfere with dopamine sensing (L-tryptophan, and uric acid) (see Supplementary Figure S6 for chemical structures). 10, 26 We tested whether these related molecules were capable of enhancing the formation of visible (615 nm emission) fluorescent nanoclusters by DNA sequence S4. Under 525 nm illumination, synthesis of S4-AgNCs in the presence of dopamine again produced a robust increase in 615 nm emission. However, synthesis in the presence of the other related molecules failed to significantly enhance fluorescent emission (Figure 4a) . We further tested whether these other molecules were capable of quenching S5-AgNC fluorescence. Again, we observed that the addition of dopamine to existing S5-AgNC caused robust quenching of fluorescence (600 nm emission, 535 nm excitation) while S5-AgNC was unaffected by addition of other tested molecules (Figure 4b) . We conclude that catecholamine precursors, dopamine metabolites, and known dopamine competitors do not significantly alter the fluorescence of these two DNA-AgNCs.
To better understand the mechanism of dopamine interaction with DNA-silver nanoclusters, we investigated the role played by the catechol group in the interactions between dopamine and DNA-AgNCs. We compared the dopamine response of S5-and S4-templated AgNCs to the corresponding catechol response (Figure 4c-d) . Again, we added dopamine, catechol, or control solution (buffer) prior to nanocluster synthesis for construct S4 and after nanocluster synthesis for construct S5. For both sensors, catechol modulated nanocluster fluorescence in a manner similar to dopamine, albeit to a lesser extent (Figure 4c-d) . Like dopamine, catechol increased the formation of visible (615 nm emission) nanoclusters, while slightly decreasing the formation of nIR nanocluster (730 emission) (Figure 4c) . Catechol also induced the quench+shift phenomenon, though to a lesser degree than dopamine (Figure 4d) . However, dopamine had a more pronounced ability to prevent nIR nanocluster assembly (Figure 4c) . This similarity suggests the catechol group is critical to the perturbation of DNA-AgNC fluorescence by dopamine. However, other molecules we tested containing a catechol group (namely DOPAC and L-DOPA) induced essentially no fluorescent change (Figure 4a-b) .
We hypothesize that selectivity for dopamine is based on the small size of its alkylamine group. All other catecholamines tested contained a bulkier alkyl group (see Supplementary Figure S6 for chemical structures), which could sterically hinder interactions with the DNA-AgNC complex. We presume that direct interactions between dopamine and the DNA strand perturb the DNAsilver nanocluster conformation. 16 Dopamine binding to template S4 before nanocluster synthesis may destabilize the conformation necessary to form the near infrared population. Similarly, dopamine could destabilize the 650 nm nanocluster population formed by sequence S5 by perturbing the conformation of the DNA. However, dopamine could also promote direct conversion from one species to another with a different emission wavelength. Alternatively, dopamine may irreversibly interact with the DNA bases, resulting in cleavage or formation of adducts. In previous reports, quinones formed by the oxidation of dopamine were observed to quench the fluorescence of certain AgNCs, potentially through irreversible DNA damage. [27] [28] [29] [30] Such modifications to the DNA bases would produce changes in fluorescence by eliminating Ag+ binding domains or orbital interactions between DNA bases and the AgNC, or by perturbing a conformation critical to cluster formation or the continued stability of a cluster after synthesis. 12, 28, 29, 31 Elucidating the mechanism of dopamine action (and especially its reversibility) will be critical to establishing this technique as a viable option for in vivo monitoring.
We conclude that DNA-stabilized AgNCs can serve as selective, sensitive, ratiometric fluorescent sensors of dopamine concentration. Specifically, we identify stabilizing DNA sequences for fluorescent silver nanoclusters that support two complementary dopamine detection approaches in vitro: one (S4) provides a "turn-on" sensor that reports on the presence of dopamine during DNA S4-AgNC synthesis and the other (S5) provides a "turn-off" sensor that is quenched by the addition of dopamine to pre-formed DNA S5-AgNCs. Both DNA sequences produce two distinct emission peaks, thereby enabling quantification of dopamine concentration using ratiometric fluorescent sensing.
Ratiometric sensors offer important advantages over conventional fluorescent sensors, which report on the presence of a target molecule through a fractional change in overall emission intensity, ∆ƒ = (F-F 0 )/F 0 , at a single emission wavelength 32 . In conventional fluorescent sensing, the magnitude of the signal is often small and both baseline and target-modulated fluorescence are susceptible to interference (due to non-uniform concentration distribution, photobleaching, aggregation or nonspecific interactions with the environment, such as local pH changes, 33, 34 ) that complicates interpretation. Ratiometric fluorescent sensors, with their two spectrally distinct fluorescent signals, can be more responsive and less susceptible to interferences, especially if the fluorophores are chemically related and/or respond similarly to environmental conditions. DNA S5-AgNCs' ratiometric signal is typical in that one of the emissions changes in response to target (dopamine) while the other remains invariant, and so can be used to scale or normalize the indicator signal. DNA S4-AgNCs' ratiometric signal offers enhanced sensitivity because its two emissions have opposite dependency on dopamine.
With proper calibration, ratiometric sensing can report not merely the presence of and directional change in a target analyte, but also its concentration. Basal dopamine concentrations in relevant brain areas, including the extracellular matrix of the striatum, are commonly 1nM-1µM, though they can be higher in the vicinity of the synapse shortly after release. 7, [35] [36] [37] [38] While the synthesis-dependent signal from DNA S4-AgNCs is sensitive in this range (10 nM -100 µM), the sensitivity and working range of the post-synthesis responsive (and therefore in vivo compatible) DNA S5-AgNC nanosensor (1-100 µM) falls outside these commonly measured values. Ratiometric fluorescent sensors are generally challenging to engineer, 34 but the sequence modularity of DNA-AgNCs offers a flexible new toolkit. Improvements in sensitivity might be achieved through directed mutation or automated screens of DNA sequence and nanocluster synthesis space. Given the documented successes of such screens 39 as well as the ability to engineer FRET pairs, 40 there is a real possibility of discovering clusters with sufficient sensitivities and temporal responses to enable real-time, quantitative imaging of neurotransmitters in vivo.
In summary, we present DNA-silver nanoclusters as novel, low-cost, easy-to-assemble, biocompatible reporters that offer selective, optical, quantitative sensing of dopamine concentration in vitro. With further development, DNA-stabilized AgNCs may enable spatially distributed, real-time, quantitative, optical monitoring of dopamine in vivo.
FIGURES

Figure 1. Changes in DNA-AgNC fluorescence in the presence of neurotransmitter.
Top panels: Schematic representation of experimental approach. (a) We synthesized silver nanoclusters (AgNCs) using 6 DNA sequences (S1-S6) and determined the fluorescence emission spectra of each nanocluster. For these initial screens, we used UV excitation (260 nm, purple) because it universally excites fluorescent DNA-AgNCs regardless of their specific visible excitation spectra. 25 Bottom: Fluorescence emission spectra of each DNA-AgNC. DNA sequences S2 and S3 had emission spectra similar to those of S5 and were thus omitted for clarity. In the presence of dopamine, intensity at the lower wavelength emission peak (615 nm) more than doubles while intensity at the higher wavelength peak (730 nm emission) drops a comparable amount. (e) Fluorescence emission response of the two spectrally distinct AgNCs generated by S4 when different concentrations of dopamine are added prior to cluster synthesis. Orange triangles: 535 nm excitation, 615 nm emission nanoclusters; red circles: 640 nm excitation, 730 nm emission nanoclusters. One of the two AgNCs species (730 nm emission, red) was significantly quenched by moderate amounts of dopamine, while the other species (615 nm emission, orange) was enhanced by moderate amounts of dopamine. 
METHODS
Chemicals.
Unless otherwise noted, chemicals were purchased from Sigma Aldrich (St. Louis, MO, USA): Dopamine hydrochloride, Acetylcholine chloride (≥99% TLC), Histamine dihydrochloride (≥99.0% AT), γ-Aminobutyric acid (GABA) (BioXtra, ≥99%), L-Aspartic Acid (reagent grade, ≥98% HPLC), Glycine (from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, ≥98.5%), Epinephrine hydrochloride, L-Glutamic acid (ReagentPlus ® , ≥99% HPLC), Uric acid (≥99%, crystalline), 3,4-Dihydroxy-L-phenylalanine (L-DOPA) (≥98% TLC), L-tryptophan (reagent grade, ≥98% HPLC)), L-Tyrosine (BioUltra, ≥99.0% NT), 3,4-Dihydroxyphenylacetic acid (DOPAC) (98%), L-Phenylalanine (reagent grade, ≥98%), (−)-Norepinephrine (≥98%, crystalline). Figure 1c ), 12.5 µL of 1.6 mM AgNO 3 was added to the DNA solution and allowed to incubate in the dark for 10-20 minutes. Next, 12.5 µL of freshly prepared 0.8 mM NaBH 4 diluted in 100 µM NaOH was added to the DNA-Ag solution. The solution was vortexed and left to react in the dark for 16-20 hours at 4°C. 10 µL samples of the resulting DNA-AgNCs were placed in a 384-well plate (Product #3821BC, Corning, Inc.) and combined with 10 µL of a 100 µM neurotransmitter solution or DI water as a control. The final concentration of DNA was 12.5 µM. Each sample was prepared in triplicate. The well plate incubated for 2-4 hours in the dark at 4°C until measurements were taken.
Oligonucleotides. DNA oligos (detailed in
Fluorescence detection. Fluorescence excitation and emission spectra of each sample were measured using a Tecan Infinite 200Pro plate reader with Tecan i-control software (Tecan Group Ltd.) between 1 and 5 hours after either chemical reduction or addition of NTs.
Step size and bandwidth were set to 2 nm and 20 nm for emission scans, and to 5 nm and 5-10 nm for excitation scans, respectively. All scans were performed using Top Mode. The gain was kept constant at 105 (when using 260 nm excitation) or at 75 (when using visible excitation). Empty wells were processed to check for autofluorescence of the wellplate. For each DNA-AgNC, we recorded the proportional change in fluorescence, ∆ƒ = (F-F 0 )/F 0 , of a single emission wavelength in the presence of each NT (Figure 1b-c) . We used the peak emission intensity at peak visible excitation in the absence of NTs (F 0 ) and the emission intensity at the same excitation and emission wavelengths in the presence of NTs (F).
SAFETY.
No unexpected, new, and/or significant hazards or risks associated with the reported work were encountered.
SUPPORTING INFORMATION.
Supporting Information is available free of charge on the ACS Publications website. Fluorescence emission spectra of all DNA sequences ( Supplementary Figure 1) ; distinct spectral populations for sequence S4 (Supplementary Figure 2 ) and sequence S5 (Supplementary Figure  4) ; ratiometric responses to dopamine concentration (Supplementary Figure 3) ; and structural formulas for neurotransmitters and small molecules in the screening library ( Supplementary  Figures 5 and 6 ) are provided.
ABBREVIATIONS.
DNA-AgNC = DNA-stabilized silver nanocluster DOPAC = 3,4-Dihydroxyphenylacetic acid L-DOPA = 3,4-Dihydroxy-L-phenylalanine GABA = γ-Aminobutyric acid NT = neurotransmitter
